authors
- Lalani, Aly-Khan
- Swaminath, Anand
- Pond, Gregory
- Kapoor, Anil
- Chu, William
- Bramson, Jonathan
- Surette, Michael
- Levine, Mark Norman
- Hotte, Sebastien
Phase II trial of cytoreductive stereotactic hypofractionated radiotherapy with combination ipilimumab/nivolumab for metastatic kidney cancer (CYTOSHRINK)
Conferences
- Overview
- Research
- Additional Document Info
- View All
Overview
status
publication date
- February 20, 2020
has subject area
- 1103 Clinical Sciences (FoR)
- 1112 Oncology and Carcinogenesis (FoR)
- Oncology & Carcinogenesis (Science Metrix)
published in
- Journal of Clinical Oncology Journal